Marinus Pharmaceuticals
MRNS
$1.51
Share price
4.14%
Change (1 day)
-83.22%
Change (1 year)
Categories
Marinus Pharmaceuticals (MRNS) - Total debt
Total debt on the balance sheet as of December 2023 : $73.74 M
According to Marinus Pharmaceuticals's latest financial reports the company's total debt is $73.74 M. A company’s total debt is the sum of all current and non-current debts.
Marinus Pharmaceuticals - Total debt on balance sheet (from 2013 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $73.74 M | 2.92% |
| 2022-12-31 | $71.65 M | 65.32% |
| 2021-12-31 | $43.34 M | 1323.92% |
| 2020-12-31 | $3.04 M | 582.51% |
| 2019-12-31 | $0.44 M | |
| 2018-12-31 | $N/A | |
| 2016-12-31 | $5.24 M | -28.8% |
| 2015-12-31 | $7.36 M | 5.2% |
| 2014-12-31 | $7 M | |
| 2013-12-31 | $N/A | -100% |
| 2012-12-31 | $2.67 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Supernus Pharmaceuticals
SUPN | $41.52 M | -43.69% | 🇺🇸 USA |
 Endo International
ENDPQ | $5.08 M | -93.10% | 🇮🇪 Ireland |
 AcelRx Pharmaceuticals
ACRX | $3.36 M | -95.43% | 🇺🇸 USA |
 Eagle Pharmaceuticals
EGRX | $71.61 M | -2.89% | 🇺🇸 USA |